ReviewMikrochimica acta2026
Recent advances in 3D printing for biochemical and environmental analysis.
Review in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three-dimensional (3D) printing has evolved from a prototyping tool into a versatile manufacturing platform for biochemical and environmental analysis. This review summarizes recent advances in the main additive manufacturing routes relevant to analytical applications, including fused filament fabrication (FFF), stereolithography (SLA), digital light processing (DLP), two-photon polymerization (TPP), and inkjet-based printing. We critically discuss how printing modality, material selection, and post-fabrication functionalization determine device performance in representative applications such as lab-on-a-chip systems, droplet microfluidics, enzyme-immobilized electrodes, DNA/RNA detection devices, wearable and portable biosensors, lateral flow platforms, and environmental monitoring systems. Particular emphasis is placed on the growing roles of hybrid manufacturing, nanomaterial integration, bioprinting, and AI-assisted sensing. Although substantial progress has been achieved, major translational barriers remain, including limited material libraries, insufficient biocompatibility and chemical stability, resolution and surface-quality constraints, lack of standardization, and incomplete regulatory pathways. Future development will depend on multifunctional printable materials, improved process control, integrated system design, and validation frameworks that support scalable, field-deployable analytical devices. Overall, 3D printing is emerging as a key enabling technology for next-generation analytical platforms across biomedical, food, and environmental applications.
Indexed as
Identifiers
42024290What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.